Cargando…
Generation and Characterization of a Nanobody Against SARS-CoV
The sudden emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) has caused global panic in 2003, and the risk of SARS-CoV outbreak still exists. However, no specific antiviral drug or vaccine is available; thus, the development of therapeutic antibodies against SARS-CoV is needed. I...
Autores principales: | Li, Jiang-Fan, He, Lei, Deng, Yong-Qiang, Qi, Shu-Hui, Chen, Yue-Hong, Zhang, Xiao-Lu, Hu, Shi-Xiong, Fan, Rui-Wen, Zhao, Guang-Yu, Qin, Cheng-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369142/ https://www.ncbi.nlm.nih.gov/pubmed/34403037 http://dx.doi.org/10.1007/s12250-021-00436-1 |
Ejemplares similares
-
Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021) -
Structural basis of nanobodies neutralizing SARS-CoV-2 variants
por: Shi, Zhenzhong, et al.
Publicado: (2022) -
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021) -
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2
por: Li, Tingting, et al.
Publicado: (2022) -
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)